» Articles » PMID: 11696718

How Do Patients with Interstitial Cystitis Present?

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2001 Nov 7
PMID 11696718
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We determined how interstitial cystitis progresses from initial symptoms to diagnosis.

Materials And Methods: We retrospectively analyzed the records of 45 patients to determine the dates of symptom onset and diagnosis, and sequence of urgency/frequency, nocturia and pain. We also documented alternate and previous diagnoses, and previous surgical treatments.

Results: Of the patients 89% presented with only 1 symptom. Median time from the initial symptom to all symptoms was 2 years (mean 5.5). The most common previous diagnoses were urinary infection in 19 cases, a gynecologic diagnosis in 14 and urethral diagnoses in 6. A previous urinary infection was documented in only 1 of 19 patients, while 11 had undergone hysterectomy and 5 diagnosed with endometriosis had no pathological documentation available.

Conclusions: Early interstitial cystitis presents variably and usually with only a single symptom of urgency/frequency, nocturia or pain. Clinicians may fail to appreciate the symptoms of early interstitial cystitis, which leads to delayed diagnosis until the patient is more symptomatic. With time multiple symptoms manifest. Bacterial cystitis, prostatitis, endometriosis and chronic pelvic pain are common initial misdiagnoses. Interstitial cystitis should be considered when laboratory documentation of alternate diagnoses is lacking or when patients fail to respond to therapy for alternate diagnoses.

Citing Articles

Exploring the anti-inflammatory effects of phytochemicals in attenuating interstitial cystitis-a literature review.

Anjum I, Nasir A, Naseer F, Ibrahim A, Rehman B, Bashir F Front Pharmacol. 2025; 16:1483548.

PMID: 39974737 PMC: 11836544. DOI: 10.3389/fphar.2025.1483548.


The Evil Twins of Chronic Pelvic Pain Syndrome: A Systematic Review and Meta-Analysis on Interstitial Cystitis/Painful Bladder Syndrome and Endometriosis.

Inzoli A, Barba M, Costa C, Carazita V, Cola A, Fantauzzi M Healthcare (Basel). 2024; 12(23).

PMID: 39685025 PMC: 11641437. DOI: 10.3390/healthcare12232403.


Effect of pro-inflammatory cytokines on urothelial cell adenosine triphosphate release and breakdown.

Kaleska B, Sluyter R, Chen Z, Mansfield K Bladder (San Franc). 2024; 11(2):e21200006.

PMID: 39539471 PMC: 11555206. DOI: 10.14440/bladder.2024.0011.


[Optimization study of an animal model for interstitial cystitis/bladder pain syndrome based on the dose effect of cyclophosphamide].

Ke H, Wang Q, Xu K Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(5):908-912.

PMID: 39397473 PMC: 11480539.


Animal models of interstitial cystitis/bladder pain syndrome.

Tay C, Grundy L Front Physiol. 2023; 14:1232017.

PMID: 37731545 PMC: 10507411. DOI: 10.3389/fphys.2023.1232017.